The immunology informationbase and evaluation portal (ImmPort) system is the archival repository and dissemination car for scientific and molecular informationunits created by analysis consortia funded by the Nationwide Institute of Allergy and Infectious Illnesses Division of Allergy, Immunology, and Transplantation.
With almost 100 informationunits now publicly out there and lots of of downloads per thirty days, ImmPort is a vital supply for uncooked information and protocols from scientific trials, mechanistic research, and novel strategies for mobile and molecular measurements.
To facilitate information switch, templates for information illustration and customary working procedures have additionally been created and are additionally publicly out there. ImmPort facilitates transparency and reproducibility in immunology analysis, serves as an vital useful resource for training, and allows newly generated hypotheses and information-driven science.
Cognitive management deficits in schizophrenia: mechanisms and that means.
Though schizophrenia is an sickness that has been traditionally characterised by the presence of optimistic symptomatology, a long time of analysis spotlight the significance of cognitive deficits on this dysfunction. This overview proposes that the theoretical mannequin of cognitive management, which is predicated on up to date cognitive neuroscience, supplies a unifying principle for the cognitive and neural abnormalities underlying larger cognitive dysfunction in schizophrenia.
To help this mannequin, we define converging proof from a number of modalities (eg, structural and purposeful neuroimaging, pharmacological information, and animal fashions) and samples (eg, scientific excessive danger, genetic excessive danger, first episode, and power topics) to emphasise how dysfunction in cognitive management mechanisms supported by the prefrontal cortex contribute to the pathophysiology of upper cognitive deficits in schizophrenia.
Our mannequin supplies a theoretical hyperlink between mobile abnormalities (eg, reductions in dentritic spines, interneuronal dysfunction), purposeful disturbances in native circuit perform (eg, gamma abnormalities), altered inter-regional cortical connectivity, a variety of upper cognitive deficits, and symptom presentation (eg, disorganization) within the dysfunction.
Lastly, we talk about current advances within the neuropharmacology of cognition and the way they will inform a focused method to the event of efficient therapies for this disabling side of schizophrenia.

Giant-scale serial evaluation of gene expression reveals genes differentially expressed in ovarian most cancers.
Difficulties within the detection, prognosis, and remedy of ovarian most cancers lead to an general low survival price of girls with this illness. A greater understanding of the pathways concerned in ovarian tumorigenesis will doubtless present new targets for early and efficient intervention.
Right here, now we have used serial evaluation of gene expression (SAGE) to generate world gene expression profiles from numerous ovarian cell traces and tissues, together with major cancers, ovarian floor epithelia cells, and cystadenoma cells. The profiles have been used to check general patterns of gene expression and to establish differentially expressed genes.
We’ve got sequenced a complete of 385,000 tags, yielding >56,000 genes expressed in 10 totally different libraries derived from ovarian tissues. On the whole, ovarian most cancers cell traces confirmed comparatively excessive ranges of similarity to libraries from different most cancers cell traces, whatever the tissue of origin (ovarian or colon), indicating that these traces had misplaced lots of their tissue-specific expression patterns.
In distinction, immortalized ovarian floor epithelia and ovarian cystadenoma cells confirmed a lot larger similarity to major ovarian carcinomas than to major colon carcinomas. Major tissue specimens subsequently seemed to be a greater mannequin for gene expression analyses.
Utilizing the expression profiles described above and stringent choice standards, now we have recognized a lot of genes extremely differentially expressed between nontransformed ovarian epithelia and ovarian carcinomas. A number of the genes recognized are already identified to be overexpressed in ovarian most cancers, however a number of signify novel candidates.
Lots of the genes up-regulated in ovarian most cancers signify floor or secreted proteins comparable to claudin-Three and -4, HE4, mucin-1, epithelial mobile adhesion molecule, and mesothelin. Curiously, each apolipoprotein E (ApoE) and ApoJ, two proteins concerned in lipid homeostasis, are among the many genes extremely up-regulated in ovarian most cancers.
Chosen serial evaluation of gene expression outcomes have been additional validated by immunohistochemical evaluation of ApoJ, claudin-3, claudin-4, and epithelial mobile adhesion molecule in archival materials. These experiments offered further proof of the relevance of our findings in vivo. The publicly out there expression information reported right here ought to stimulate and support additional analysis within the area of ovarian most cancers.
Deoxynivalenol: toxicology and potential results on people.
Deoxynivalenol (DON) is a mycotoxin that generally contaminates cereal-based meals worldwide. On the molecular degree, DON disrupts regular cell perform by inhibiting protein synthesis by way of binding to the ribosome and by activating essential mobile kinases concerned in sign transduction associated to proliferation, differentiation, and apoptosis.
Relative to toxicity, there are marked species variations, with the pig being most delicate to DON, adopted by rodent>> canine>> cat>> poultry>> ruminants. The physiologic parameter that’s most delicate to low-level DON publicity is the emetic response, with as little as 0.05 to 0.1 mg/kg physique weight (bw) inducing vomiting in swine and canines.
Chinese language epidemiological research recommend that DON might also produce emetic results in people. With respect to power results, development (anorexia and decreased dietary effectivity), immune perform, (enhancement and suppression), and replica (lowered litter measurement) are additionally adversely affected by DON in animals, whereas incidence of neoplasia will not be affected.
When hazard evaluations have been carried out utilizing present power toxicity information and customary security components employed for anthropogenic components/contaminants in meals, tolerable day by day intakes (TDIs) starting from 1 to five microg/kg bw have been generated.
On condition that essential information gaps nonetheless exist concerning the potential well being results of DON, further analysis is required to enhance capability for assessing hostile well being results of this mycotoxin.
Vital areas for future DON analysis embrace molecular mechanisms underlying toxicity, sensitivity of human cells/tissues relative to different species, emetic results in primates, epidemiological affiliation with gastroenteritis and power illness in people, and surveillance in cereal crops worldwide.
The sort VI secretion toolkit.
Bacterial secretion programs are macromolecular complexes that launch virulence components into the medium or translocate them into the goal host cell. These programs are widespread in micro organism permitting them to contaminate eukaryotic cells and survive or replicate inside them.
A brand new secretion system, the kind VI secretion system (T6SS), was lately described and characterised in a number of pathogens. Genomic information recommend that T6SS exist in most micro organism that come into shut contact with eukaryotic cells, together with plant and animal pathogens.
P388D1 Cell Line (Mouse monocyte/macrophage cells) |
|||
| 116032 | Antibody Research Corporation | 1 Vial | Ask for price |
P388D1 Cell Line (Mouse monocyte/macrophage cells) |
|||
| 116032L | Antibody Research Corporation | 0.5 mg | Ask for price |
P388D1 Cell Line (Mouse monocyte/macrophage cells) |
|||
| 116032R | Antibody Research Corporation | 100 µg | Ask for price |
MagIso Pan Monocyte Cell Isolation Kit, Human |
|||
| WHK-B021 | Creative Diagnostics | 20 tests, 200 tests | Ask for price |
Human Monocyte-Derived Dendritic Cells |
|||
| ABC-TC3708 | AcceGen | 1 vial | Ask for price |
|
Description: Human Monocyte-Derived Dendritic Cells provide an ideal culture model for the study of the initiation of immune responses, delivery of antigens to dendritic cells, cytokine production, vaccines and Toll-like receptors (TLRs). Dendritic Cells are derived from monocytes that have been cultured with IL-4 and GM-CSF. Our Dendritic Cells are quality tested via flow cytometry to ensure proper expression of dendritic markers. Dendritic cells express CD11c and HLA-DR. The expression of CD3 (T cells), CD19 (B cells), CD14 (monocytes/macrophages), and CD80 (a maturation marker) is also analyzed to ensure depletion of these cell types. Cell Features:Dendritic Cells are derived from monocytes cultured with interleukin 4 and granulocyte-monocyte colony stimulating factor.Dendritic Cells are extensively tested for quality and optimal performance.Gentaur guarantees performance and quality. |
|||
Human Monocyte-Derived Dendritic Cells |
|||
| CSC-C1676 | Creative Bioarray | One Frozen vial | Ask for price |
Human Primary Monocyte-derived Dendritic Cells |
|||
| T5403 | ABM | 5x10^5 cells / 1.0 ml | EUR 975 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|||
| MBS6282773-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|||
| MBS6282773-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|||
| MBS6282774-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|||
| MBS6282774-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|||
| MBS6282775-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|||
| MBS6282775-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|||
| MBS6282776-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|||
| MBS6282776-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|||
| MBS6282777-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|||
| MBS6282777-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|||
| MBS6282783-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|||
| MBS6282783-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|||
| MBS6282784-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|||
| MBS6282784-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|||
| MBS6282785-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|||
| MBS6282785-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|||
| MBS6282786-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|||
| MBS6282786-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|||
| MBS6282787-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|||
| MBS6282787-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|||
| MBS6282788-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|||
| MBS6282788-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|||
| MBS6282794-02mL | MyBiosource | 0.2mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|||
| MBS6282794-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
293AD Cell Line |
|||
| AD-100 | Cell Biolabs | 1 vial | EUR 308 |
|
Description: N/A |
|||
293AAV Cell Line |
|||
| AAV-100 | Cell Biolabs | 1 vial | EUR 340 |
|
Description: N/A |
|||
293LTV Cell Line |
|||
| LTV-100 | Cell Biolabs | 1 vial | EUR 340 |
|
Description: N/A |
|||
293RTV Cell Line |
|||
| RV-100 | Cell Biolabs | 1 vial | EUR 340 |
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325 | Cell Biolabs | 96 assays | EUR 1027.2 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325-5 | Cell Biolabs | 5 x 96 assays | EUR 4033.2 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
| CBA-135 | Cell Biolabs | 96 assays | EUR 596 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
| CBA-135-5 | Cell Biolabs | 5 x 96 assays | EUR 2592 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
| CBA-140 | Cell Biolabs | 96 assays | EUR 624 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
| CBA-140-5 | Cell Biolabs | 5 x 96 assays | EUR 2700 |
293/GFP Cell Line |
|||
| AKR-200 | Cell Biolabs | 1 vial | EUR 388 |
|
Description: Fluorescence |
|||
T47D/GFP Cell Line |
|||
| AKR-208 | Cell Biolabs | 1 vial | EUR 686.4 |
|
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
A549/GFP Cell Line |
|||
| AKR-209 | Cell Biolabs | 1 vial | EUR 388 |
|
Description: Fluorescence |
|||
HeLa/GFP Cell Line |
|||
| AKR-213 | Cell Biolabs | 1 vial | EUR 388 |
|
Description: Fluorescence |
|||
293/Cas9 Cell Line |
|||
| AKR-5110 | Cell Biolabs | 1 vial | EUR 460 |
HeLa/Cas9 Cell Line |
|||
| AKR-5111 | Cell Biolabs | 1 vial | EUR 460 |
NIH3T3/GFP Cell Line |
|||
| AKR-214 | Cell Biolabs | 1 vial | EUR 388 |
|
Description: Fluorescence |
|||
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|||
| MBS6282778-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|||
| MBS6282778-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|||
| MBS6282779-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|||
| MBS6282779-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|||
| MBS6282780-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|||
| MBS6282780-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|||
| MBS6282781-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|||
| MBS6282781-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|||
| MBS6282782-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|||
| MBS6282782-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|||
| MBS6282789-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|||
| MBS6282789-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|||
| MBS6282790-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|||
| MBS6282790-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|||
| MBS6282791-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|||
| MBS6282791-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|||
| MBS6282792-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|||
| MBS6282792-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|||
| MBS6282793-01mL | MyBiosource | 0.1mL | EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|||
| MBS6282793-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
NIH3T3/Cas9 Cell Line |
|||
| AKR-5104 | Cell Biolabs | 1 vial | EUR 460 |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
|||
| CBA-135-T | Cell Biolabs | 24 assays | EUR 518.4 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
MCF-7/Luc Cell Line |
|||
| AKR-234 | Cell Biolabs | 1 vial | EUR 686.4 |
|
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
SKOV-3/Luc Cell Line |
|||
| AKR-232 | Cell Biolabs | 1 vial | EUR 686.4 |
|
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
OVCAR-5/RFP Cell Line |
|||
| AKR-254 | Cell Biolabs | 1 vial | EUR 686.4 |
|
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
|||
| CBA-140-T | Cell Biolabs | 24 assays | EUR 547.2 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
Macrophage/Monocyte Antibody |
|||
| abx415014-025mg | Abbexa | 0.25 mg | EUR 777.6 |
Macrophage/Monocyte Antibody |
|||
| abx415014-200l | Abbexa | 200 µl | EUR 550 |
Macrophage/Monocyte Antibody |
|||
| abx415015-200l | Abbexa | 200 µl | EUR 200 |
Macrophage/Monocyte Antibody |
|||
| abx415015-25ug | Abbexa | 25 ug | EUR 360 |
Monocyte/Macrophage Antibody |
|||
| abx415176-025mg | Abbexa | 0.25 mg | EUR 710.4 |
Monocyte/Macrophage Antibody |
|||
| abx415176-200l | Abbexa | 200 µl | EUR 512.5 |
Monocyte Pervanadate Control |
|||
| MBS474439-01mL | MyBiosource | 0.1mL | EUR 200 |
Monocyte Pervanadate Control |
|||
| MBS474439-5x01mL | MyBiosource | 5x0.1mL | EUR 740 |
Monocyte + Pervanadate Treated |
|||
| MBS474440-01mL | MyBiosource | 0.1mL | EUR 200 |
Monocyte + Pervanadate Treated |
|||
| MBS474440-5x01mL | MyBiosource | 5x0.1mL | EUR 740 |
Monocyte/Granulocyte Antibody |
|||
| abx415381-01mg | Abbexa | 0.1 mg | EUR 543.6 |
Monocyte/Granulocyte Antibody |
|||
| abx415381-200l | Abbexa | 200 µl | EUR 362.5 |
Monocyte (PMA-differentiated) |
|||
| MBS474438-01mL | MyBiosource | 0.1mL | EUR 200 |
Monocyte (PMA-differentiated) |
|||
| MBS474438-5x01mL | MyBiosource | 5x0.1mL | EUR 740 |
Collagen-based Cell Contraction Assay |
|||
| CBA-201 | Cell Biolabs | 24 assays | EUR 348 |
Radius 384-Well Cell Migration Assay |
|||
| CBA-127 | Cell Biolabs | 384 assays | EUR 721.2 |
|
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 384-Well Cell Migration Assay |
|||
| CBA-127-5 | Cell Biolabs | 5 x 384 wells | EUR 2802 |
|
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) |
|||
| MBS6507133-01mg | MyBiosource | 0.1mg | EUR 800 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) |
|||
| MBS6507133-5x01mg | MyBiosource | 5x0.1mg | EUR 3445 |
HIF-1 Alpha Cell Based ELISA Kit |
|||
| CBA-281 | Cell Biolabs | 96 assays | EUR 734.4 |
|
Description: Cell Biolabs? HIF-1 Cell Based ELISA Kit is an immunoassay developed for rapid detection of HIF-1 Alpha in fixed cells. Cells on a microplate are stimulated for HIF-1 Alpha stabilization, fixed, permeabilized, and then neutralized in the well. HIF-1 Alpha is then detected with an anti-HIF-1 alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays and can detect HIF-1 Alpha from human, mouse, or rat. |
|||
CytoSelect™ MTT Cell Proliferation Assay |
|||
| CBA-252 | Cell Biolabs | 960 assays | EUR 268 |
THP-1 Cell Slide (Human (1 yr infant, Male) peripheral blood monocyte, acute monocytic leukemia) (5 slides/pk) |
|||
| HCLS-17008 | Alpha Diagnostics | 1 pk | EUR 300 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E01A14606 | BlueGene | 96T | EUR 700 |
|
Description: ELISA |
|||
Dog Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E08M0246-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E08M0246-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E08M0246-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Cat Monocyte Chemotactic Protein 1/Monocyte Chemotactic and Activating Factor ELISA Kit |
|||
| MBS081193-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rat Monocyte Chemotactic Protein 1/Monocyte Chemotactic and Activating Factor ELISA Kit |
|||
| MBS012407-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Rat Monocyte Chemotactic Protein 1/Monocyte Chemotactic and Activating Factor ELISA Kit |
|||
| MBS012407-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Rat Monocyte Chemotactic Protein 1/Monocyte Chemotactic and Activating Factor ELISA Kit |
|||
| MBS012407-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Rat Monocyte Chemotactic Protein 1/Monocyte Chemotactic and Activating Factor ELISA Kit |
|||
| MBS012407-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E02M0246-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E02M0246-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E02M0246-48wellsplate | BlueGene | 48 wells plate | EUR 280 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E02M0246-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E02M0246-96wellsplate | BlueGene | 96 wells plate | EUR 405 |
Pig Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E07M0246-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E07M0246-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA kit |
|||
| E07M0246-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Monocyte chemotactic protein 1/monocyte chemotactic and activating factor in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA Kit |
|||
| MBS726161-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 5685 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA Kit |
|||
| MBS726161-48StripWells | MyBiosource | 48-Strip-Wells | EUR 485 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA Kit |
|||
| MBS726161-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3020 |
Rat Monocyte chemotactic protein 1/monocyte chemotactic and activating factor ELISA Kit |
|||
| MBS726161-96StripWells | MyBiosource | 96-Strip-Wells | EUR 690 |
Rat Monocyte Chemotactic Protein 1/Monocyte Chemotactic And Activating Factor ELISA Kit |
|||
| BG-RAT11545 | Novatein Biosciences, Inc. | 1 Each | Ask for price |
Monocyte Calyculin A Control |
|||
| MBS474435-01mL | MyBiosource | 0.1mL | EUR 200 |
Monocyte Calyculin A Control |
|||
| MBS474435-5x01mL | MyBiosource | 5x0.1mL | EUR 740 |
Monocyte + Calyculin A Treated |
|||
| MBS474436-01mL | MyBiosource | 0.1mL | EUR 200 |
Monocyte + Calyculin A Treated |
|||
| MBS474436-5x01mL | MyBiosource | 5x0.1mL | EUR 740 |
Radius™ 24-Well Cell Migration Assay |
|||
| CBA-125 | Cell Biolabs | 24 assays | EUR 356 |
|
Description: Excepted Quantities |
|||
Radius™ 24-Well Cell Migration Assay |
|||
| CBA-125-5 | Cell Biolabs | 5 x 24 assays | EUR 1516 |
|
Description: Excepted Quantities |
|||
Radius™ 96-Well Cell Migration Assay |
|||
| CBA-126 | Cell Biolabs | 96 assays | EUR 416 |
|
Description: Excepted Quantities |
|||
Many analysis teams at the moment are investigating the underlying mechanisms and the way in which through which the effector proteins translocated by this machine subvert host defences. This overview supplies an outline of our present information about sort VI secretion, specializing in gene regulation, parts of the secretion machine, substrate secretion and the mobile penalties for the host cell.